GlassScriptPhysician profile
Sophia Rahman
NPI 1831266741
$427.19
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $72.87 · 2021: $48.11 · 2022: $60.34 · 2023: $53.17 · 2024: $25.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $93.67 | 2019-2024 | |
| Tersera Therapeutics LLC | $69.70 | 2019 | |
| Amgen INC. | $55.61 | 2020-2021 | |
| Pharmacyclics LLC, An Abbvie Company | $32.91 | 2022 | |
| Irhythm Technologies, INC. | $27.43 | 2022 | |
| Elekta, INC. | $23.99 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.91 | 2019 | |
| Genzyme Corporation | $20.85 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.53 | 2020 | |
| Eisai INC. | $18.99 | 2019 | |
| Abbvie INC. | $18.99 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.68 | 2019 | |
| Janssen Biotech, INC. | $7.93 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sophia Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.